The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Association of metformin use with cancer incidence and mortality: A meta-analysis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Currie, C. J., Poole, C. D., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1440-6 · Cited by 1,124
New Users of Metformin Are at Low Risk of Incident Cancer
Libby, G., Donnelly, L. A., Donnan, P. T., Alessi, D. R., Morris, A. D., & Evans, J. M. M. (2009) · Diabetes Care · doi:10.2337/dc08-2175 · Cited by 996
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
DeCensi, A., Puntoni, M., Goodwin, P., Cazzaniga, M., Gennari, A., Bonanni, B., & Gandini, S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0157 · Cited by 918
Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies
Ben, Q., Xu, M., Ning, X., Liu, J., Hong, S., Huang, W., Zhang, H., & Li, Z. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.003 · Cited by 685 · cited 1×
“33), and to a less extent for pancreatic cancer [57] (OR = 1.”
BackgroundHemkens, L. G., Grouven, U., Bender, R., Günster, C., Gutschmidt, S., Selke, G. W., & Sawicki, P. T. (2009) · Diabetologia · doi:10.1007/s00125-009-1418-4 · Cited by 607
Antidiabetic Therapies Affect Risk of Pancreatic Cancer
Li, D., Yeung, S. J., Hassan, M. M., Konopleva, M., & Abbruzzese, J. L. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.013 · Cited by 584
Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis
Noto, H., Goto, A., Tsujimoto, T., & Noda, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033411 · Cited by 566
Giovannucci, E., & Michaud, D. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.050 · Cited by 543
Metabolic syndrome, hyperinsulinemia, and colon cancer: a review
Giovannucci, E. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.836s · Cited by 531
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes
Landman, G. W. D., Kleefstra, N., van Hateren, K. J. J., Groenier, K. H., Gans, R. O. B., & Bilo, H. J. G. (2010) · Diabetes Care · doi:10.2337/dc09-1380 · Cited by 502
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Bodmer, M., Meier, C., Krähenbühl, S., Jick, S. S., & Meier, C. R. (2010) · Diabetes Care · doi:10.2337/dc09-1791 · Cited by 466
Cusi, K. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.11.4059 · Cited by 455
Mortality After Incident Cancer in People With and Without Type 2 Diabetes
Currie, C. J., Poole, C. D., Jenkins-Jones, S., Gale, E. A. M., Johnson, J. A., & Morgan, C. L. (2012) · Diabetes Care · doi:10.2337/dc11-1313 · Cited by 398
Lee, M.-S., Hsu, C.-C., Wahlqvist, M. L., Tsai, H.-N., Chang, Y.-H., & Huang, Y.-C. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-20 · Cited by 380
Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence
Xue, F., & Michels, K. B. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.823s · Cited by 353
Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma
Hassan, M. M., Curley, S. A., Li, D., Kaseb, A., Davila, M., Abdalla, E. K., Javle, M., Moghazy, D. M., Lozano, R. D., Abbruzzese, J. L., et al. (2010) · Cancer · doi:10.1002/cncr.24982 · Cited by 309
Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer
Sadeghi, N., Abbruzzese, J. L., Yeung, S.-C. J., Hassan, M., & Li, D. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2994 · Cited by 305
Donadon, V., Balbi, M., Mas, M. D., Casarin, P., & Zanette, G. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02223.x · Cited by 292
Metformin and cancer: new applications for an old drug
Kourelis, T. V., & Siegel, R. D. (2012) · Medical Oncology · doi:10.1007/s12032-011-9846-7 · Cited by 289
Wright, J. L., & Stanford, J. L. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9407-y · Cited by 276
The Effects of Family Therapies for Adolescent Delinquency and Substance Abuse: A Meta‐analysis
Baldwin, S. A., Christian, S., Berkeljon, A., & Shadish, W. R. (2012) · Journal of Marital and Family Therapy · doi:10.1111/j.1752-0606.2011.00248.x · Cited by 244
Piccinni, C., Motola, D., Marchesini, G., & Poluzzi, E. (2011) · Diabetes Care · doi:10.2337/dc10-2412 · Cited by 239
Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives
Ruiter, R., Visser, L. E., van Herk-Sukel, M. P. P., Coebergh, J.-W. W., Haak, H. R., Geelhoed-Duijvestijn, P. H., Straus, S. M. J. M., Herings, R. M. C., & Stricker, B. H. C. (2012) · Diabetes Care · doi:10.2337/dc11-0857 · Cited by 232
Diabetes, Metformin, and Breast Cancer in Postmenopausal Women
Chlebowski, R. T., McTiernan, A., Wactawski-Wende, J., Manson, J. E., Aragaki, A. K., Rohan, T., Ipp, E., Kaklamani, V. G., Vitolins, M., Wallace, R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.7505 · Cited by 214
Metformin and cancer: Doses, mechanisms and the dandelion and hormetic phenomena
Martin-Castillo, B., Vazquez-Martin, A., Oliveras-Ferraros, C., & Menendez, J. A. (2010) · Cell Cycle · doi:10.4161/cc.9.6.10994 · Cited by 212
He, X., Esteva, F. J., Ensor, J., Hortobagyi, G. N., Lee, M.-H., & Yeung, S.-C. J. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr534 · Cited by 207
Vazquez-Martin, A., Oliveras-Ferraros, C., Cufí, S., Del Barco, S., Martin-Castillo, B., & Menendez, J. A. (2010) · Cell Cycle · doi:10.4161/cc.9.18.13131 · Cited by 205
The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus
Lee, J. H., Kim, T. I., Jeon, S. M., Hong, S. P., Cheon, J. H., & Kim, W. H. (2012) · International Journal of Cancer · doi:10.1002/ijc.26421 · Cited by 204
Diabetes mellitus and risk of prostate cancer in the health professionals follow‐up study
Kasper, J. S., Liu, Y., & Giovannucci, E. (2009) · International Journal of Cancer · doi:10.1002/ijc.24044 · Cited by 180
Vazquez-Martin, A., Oliveras-Ferraros, C., Barco, S. D., Martin-Castillo, B., & Menendez, J. A. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0924-x · Cited by 179
Romero, I. L., McCormick, A., McEwen, K. A., Park, S., Karrison, T., Yamada, S. D., Pannain, S., & Lengyel, E. (2012) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3182393ab3 · Cited by 177
Bayraktar, S., Hernadez‐Aya, L. F., Lei, X., Meric‐Bernstam, F., Litton, J. K., Hsu, L., Hortobagyi, G. N., & Gonzalez‐Angulo, A. M. (2012) · Cancer · doi:10.1002/cncr.26439 · Cited by 176 · cited 2×
“First, it is superficial to evaluate the benefit of metformin by just comparing users and non-users when a dose-dependent effect may exist [22,23].”
BackgroundAssociation between diabetes mellitus and breast cancer risk: a meta-analysis of the literature.
Liao, S., Li, J., Wei, W., Wang, L., Zhang, Y., Li, J., Wang, C., & Sun, S. (2011) · PubMed · Cited by 169
Impact of Metformin on the Prognosis of Cirrhosis Induced by Viral Hepatitis C in Diabetic Patients
Nkontchou, G., Cosson, E., Aout, M., Mahmoudi, A., Bourcier, V., Charif, I., Ganne-Carrie, N., Grando-Lemaire, V., Vicaut, E., Trinchet, J.-C., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2415 · Cited by 166
Bowker, S. L., Yasui, Y., Veugelers, P., & Johnson, J. A. (2010) · Diabetologia · doi:10.1007/s00125-010-1750-8 · Cited by 165
Use of metformin and the risk of ovarian cancer: A case–control analysis
Bodmer, M., Becker, C., Meier, C., Jick, S. S., & Meier, C. R. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.06.038 · Cited by 159
He, X., Tu, S., Lee, M., & Yeung, S. J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr020 · Cited by 154
Type 2 Diabetes Mellitus and the Risk of Colorectal Cancer
Yang, Y., Hennessy, S., & Lewis, J. D. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00152-7 · Cited by 152
Bosco, J. L. F., Antonsen, S., Sørensen, H. T., Pedersen, L. H., & Lash, T. L. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0817 · Cited by 151
Metformin and the Incidence of Prostate Cancer in Patients with Type 2 Diabetes
Azoulay, L., Dell’Aniello, S., Gagnon, B., Pollak, M., & Suissa, S. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0940 · Cited by 145
Use of Antidiabetic Agents and the Risk of Pancreatic Cancer: A Case–Control Analysis
Bodmer, M., Becker, C., Meier, C., Jick, S. S., & Meier, C. R. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.483 · Cited by 143
Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan
Tseng, C. (2011) · Diabetologia · doi:10.1007/s00125-011-2171-z · Cited by 142
Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan
Tseng, C. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0369 · Cited by 132
Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
Monami, M., Colombi, C., Balzi, D., Dicembrini, I., Giannini, S., Melani, C., Vitale, V., Romano, D., Barchielli, A., Marchionni, N., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1287 · Cited by 111
Chen, T., Lin, C., Huang, P., & Wen, C. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06664.x · Cited by 107
Antidiabetic Medication and Prostate Cancer Risk: A Population-based Case-Control Study
Murtola, T. J., Tammela, T. L. J., Lahtela, J. T., & Auvinen, A. P. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn190 · Cited by 107
Bodmer, M., Becker, C., Meier, C., Jick, S. S., & Meier, C. R. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0992-t · Cited by 100
Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer
Morden, N. E., Liu, S. K., Smith, J., MacKenzie, T. A., Skinner, J., & Korc, M. (2011) · Diabetes Care · doi:10.2337/dc11-0699 · Cited by 97
Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes
Pagano, G., Tagliaferro, V., Carta, Q., Caselle, M. T., Bozzo, C., Vitelli, F., Trovati, M., & Cocuzza, E. (1983) · Diabetologia · doi:10.1007/bf00251823 · Cited by 94
Baur, D. M., Klotsche, J., Hamnvik, O. R., Sievers, C., Pieper, L., Wïttchen, H., Stalla, G. K., Schmid, R. M., Kales, S. N., & Mantzoros, C. S. (2010) · Metabolism · doi:10.1016/j.metabol.2010.09.012 · Cited by 91
Use of sulphonylurea and cancer in type 2 diabetes—The Hong Kong Diabetes Registry
Yang, X., So, W. Y., Ronald, C. W., Yu, L. W., Ko, G. T. C., Kong, A. P. S., Ng, V., Luk, A. O. Y., Ozaki, R., Tong, P. C. Y., et al. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.08.022 · Cited by 87
Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients
Bo, S., Ciccone, G., Rosato, R., Villois, P., Appendino, G., Ghigo, E., & Grassi, G. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01480.x · Cited by 86
Chung, Y. W., Han, D. S., Park, K. H., Eun, C. S., Yoo, K.-S., & Park, C. K. (2008) · Diseases of the Colon & Rectum · doi:10.1007/s10350-007-9184-1 · Cited by 79
Diabetes Mellitus Is an Independent Risk Factor for Colorectal Cancer
Sun, L., & Yu, S. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2059-x · Cited by 78
Tsao, C.-J. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.910 · Cited by 64
Lehman, D. M., Lorenzo, C., Hernández, J., & Wang, C.-P. (2012) · Diabetes Care · doi:10.2337/dc11-1829 · Cited by 62
Vázquez‐Martín, A., Oliveras‐Ferraros, C., del Barco, S., Martı́n-Castillo, B., & Menéndez, J. A. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn758 · Cited by 58
Hense, H., Kajüter, H., Wellmann, J., & Batzler, W. U. (2011) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-3-15 · Cited by 42
The influence of antidiabetic medications on the development and progression of prostate cancer
Hitron, A., Adams, V. R., Talbert, J., & Steinke, D. T. (2012) · Cancer Epidemiology · doi:10.1016/j.canep.2012.02.005 · Cited by 40
Geraldine, N., Marc, A., Truyers, C., Mathieu, C., Stefaan, B., Wami, W. M., & Buntinx, F. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.02.002 · Cited by 30
Metformin As an Addition to Conventional Chemotherapy in Breast Cancer
Grenader, T., Goldberg, A., & Shavit, L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4110 · Cited by 25
Little, M. W., Pugh, T. F., Carey, F. J., Ndokera, R., Ing, H., Robinson, R. J., Dennison, A. R., Metcalfe, M. S., Clark, A., & Hart, A. R. (2011) · Gut · doi:10.1136/gut.2011.239301.161 · Cited by 5
Metformin in the management of type 2 diabetes.
Rc, T., & Dr, H. (1989) · PubMed · Cited by 3
Cited by
Metformin in Cancer Treatment and Prevention
Morales, D. R., & Morris, A. D. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-062613-093128 · Cited by 484
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
Coyle, C., Cafferty, F. H., Vale, C., & Langley, R. E. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw410 · Cited by 452
Repurposing metformin for cancer treatment: current clinical studies
Chae, Y. K., Arya, A., Malecek, M.-K., Shin, D. S., Carneiro, B., Chandra, S., Kaplan, J., Kalyan, A., Altman, J. K., Platanias, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8194 · Cited by 316
The impact of hypoxia and its modification of the outcome of radiotherapy
Horsman, M. R., & Overgaard, J. (2016) · Journal of Radiation Research · doi:10.1093/jrr/rrw007 · Cited by 311
Repurposing metformin for the prevention of cancer and cancer recurrence
Heckman-Stoddard, B. M., DeCensi, A., Sahasrabuddhe, V. V., & Ford, L. G. (2017) · Diabetologia · doi:10.1007/s00125-017-4372-6 · Cited by 297
Metadata
- Authors
- Zhang, P., Li, H., Tan, X., Chen, L., & Wang, S.
- Venue
- Cancer Epidemiology
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 37
- Issue
- 3
- Pages
- 207-218
- ISSN
- 1877-7821 (ISSN-L)
- OpenAlex
- W2095695954
- Cited by
- 270
- References
- 65
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.